Cabioglu, N. Et Al. 2022. Are false-negative rates of sentinel lymph node biopsy after neoadjuvant chemotherapy really associated with poor prognosis in clinically node-positive disease at diagnosis?. ANNALS OF SURGICAL ONCOLOGY , vol.29, no.SUPPL 1 , 310-311.

Cabioglu, N., Karanlik, H., Igci, A., Muslumanoglu, M., Tukenmez, M., Emiroglu, S., ... Ozkurt, E.(2022). Are false-negative rates of sentinel lymph node biopsy after neoadjuvant chemotherapy really associated with poor prognosis in clinically node-positive disease at diagnosis?. ANNALS OF SURGICAL ONCOLOGY , vol.29, no.SUPPL 1, 310-311.

Cabioglu, Neslihan Et Al. "Are false-negative rates of sentinel lymph node biopsy after neoadjuvant chemotherapy really associated with poor prognosis in clinically node-positive disease at diagnosis?," ANNALS OF SURGICAL ONCOLOGY , vol.29, no.SUPPL 1, 310-311, 2022

Cabioglu, Neslihan Et Al. "Are false-negative rates of sentinel lymph node biopsy after neoadjuvant chemotherapy really associated with poor prognosis in clinically node-positive disease at diagnosis?." ANNALS OF SURGICAL ONCOLOGY , vol.29, no.SUPPL 1, pp.310-311, 2022

Cabioglu, N. Et Al. (2022) . "Are false-negative rates of sentinel lymph node biopsy after neoadjuvant chemotherapy really associated with poor prognosis in clinically node-positive disease at diagnosis?." ANNALS OF SURGICAL ONCOLOGY , vol.29, no.SUPPL 1, pp.310-311.

@article{article, author={Neslihan CABIOĞLU Et Al. }, title={Are false-negative rates of sentinel lymph node biopsy after neoadjuvant chemotherapy really associated with poor prognosis in clinically node-positive disease at diagnosis?}, journal={ANNALS OF SURGICAL ONCOLOGY}, year=2022, pages={310-311} }